Real-life use of apremilast for the treatment of psoriasis in patients with oncological comorbidities: a retrospective descriptive multicentre study in France

被引：0

作者：

Pauline Podevin

Anne-Caroline Cottencin

Coralie Becquart

Selma Azib

Adeline Duparc

Sophie Darras

Valerie Florin

Sarah Faiz

Sophie Duvert Lehembre

Delphine Staumont-Salle

Frédéric Dezoteux

机构：

[1] CHU Lille,

[2] service de dermatologie,undefined

[3] Association des dermatologues du Nord et du Pas-de-Calais (FEDERM 59-62),undefined

[4] Centre hospitalier de Valenciennes,undefined

[5] service de dermatologie,undefined

[6] Cabinet privé,undefined

[7] Centre hospitalier de Boulogne sur mer,undefined

[8] service de dermatologie,undefined

[9] Centre hospitalier de Douai,undefined

[10] service de dermatologie,undefined

[11] Centre hospitalier de Dunkerque,undefined

[12] service de dermatologie,undefined

[13] U1286 Inserm INFINITE Institute for Translational Research in Inflammation,undefined

来源：

European Journal of Dermatology | 2023年 / 33卷

关键词：

apremilast; cancer; malignancy; psoriasis;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：34 / 40

页数：6

共 50 条

[21] Psoriatic patients with a history of cancer: A real-life experience with Apremilast treatment for 104 weeks
Bernardini, Nicoletta
Skroza, Nevena
Marchesiello, Anna
Mambrin, Alessandra
Proietti, Ilaria
Tolino, Ersilia
Maddalena, Patrizia
Marraffa, Federica
Rossi, Giovanni
Volpe, Salvatore
Potenza, Concetta
DERMATOLOGIC THERAPY, 2022, 35 (10)
[22] Use of Apremilast in Combination With Other Therapies for Treatment of Chronic Plaque Psoriasis: A Retrospective Study
AbuHilal, Mohn'd
Walsh, Scott
Shear, Neil
JOURNAL OF CUTANEOUS MEDICINE AND SURGERY, 2016, 20 (04) : 313 - 316
[23] Validation of thrombotic risk factors in 1381 patients with essential thrombocythaemia: A multicentre retrospective real-life study
Stuckey, Ruth
Ianotto, Jean-Christophe
Santoro, Marco
Czyz, Anna
Perez Encinas, Manuel M.
Teresa Gomez-Casares, Maria
Noya Pereira, Maria Soledad
de Nelecz, Anna Kulikowska
Golos, Aleksandra
Lewandowski, Krzysztof
Szukalski, Lukasz
Gonzalez-Martin, Jesus M.
Wrobe, Tomasz
Sobas, Marta Anna
BRITISH JOURNAL OF HAEMATOLOGY, 2022, 199 (01) : 86 - 94
[24] Risankizumab for the treatment of moderate-to-severe psoriasis: A multicenter, retrospective, 1 year real-life study
Caldarola, Giacomo
Zangrilli, Arianna
Bernardini, Nicoletta
Bavetta, Mauro
De Simone, Clara
Graceffa, Dario
Bonifati, Claudio
Faleri, Sara
Giordano, Domenico
Mariani, Marco
Micheli, Adriana
Moretta, Gaia
Pagnanelli, Gianluca
Panasiti, Vincenzo
Provini, Alessia
Richetta, Antonio
Peris, Ketty
Bianchi, Luca
DERMATOLOGIC THERAPY, 2022, 35 (06)
[25] Real-life effectiveness and short-term (16-week) tolerance of guselkumab for psoriasis: a Belgian retrospective multicentre study
Benhadou, F.
Ghislain, P. D.
Guiot, F.
Willaert, F.
Del Marmol, V.
Lambert, J.
Soenen, R.
Fierens, H.
de la Brassinne, M.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2020, 34 (12) : E837 - E839
[26] Real-life effectiveness of tildrakizumab in chronic plaque psoriasis: A 52-week multicentre retrospective study-IL PSO (Italian landscape psoriasis)
Narcisi, Alessandra
Valenti, Mario
Gargiulo, Luigi
Ibba, Luciano
Amoruso, Fabrizio
Argenziano, Giuseppe
Bardazzi, Federico
Burlando, Martina
Carrera, Carlo Giovanni
Damiani, Giovanni
Dapavo, Paolo
Dini, Valentina
Franchi, Chiara
Girolomoni, Giampiero
Guarneri, Claudio
Loconsole, Francesco
Sampogna, Francesca
Travaglini, Massimo
Malagoli, Piergiorgio
Costanzo, Antonio
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2023, 37 (01) : 93 - 103
[27] Guselkumab for the treatment of psoriasis: a 60-week real-life multicenter retrospective experience
Bardazzi, Federico
Viviani, Filippo
Merli, Yuri
Di Lernia, Vito
Peccerillo, Francesca
Conti, Andrea
Lasagni, Claudia
Tabanelli, Michela
D'Adamio, Simone
Di Nuzzo, Sergio
Cortellazzi, Chiara
Filippi, Federica
EXPERT OPINION ON BIOLOGICAL THERAPY, 2022, 22 (12) : 1561 - 1566
[28] Real-life retrospective multicentre study to describe the use of dupilumab in paediatric patients with atopic dermatitis in Spain: Patient profile, effectiveness and safety
Baselga Torres, Eulalia
Ivars, Marta
Prat, Carolina
Vicente, Asuncion
Rodriguez, Marta Feito
Maseda Pedrero, Rocio
Martin Santiago, Ana
Giacaman, Aniza
Fernandez, Antonio Torrelo
Noguera-Morel, Lucero
Betlloch Mas, Isabel
de Berbegal Gracia, Laura
Buselli, Montserrat Evole
Pozuelo Ruiz, Monica
Bernabeu Wittel, Jose
Garcia, Maria T. Monserrat
Dominguez, Minia Campos
Galache Osuna, Cristina
Jimenez, Jorge Santos-Juanes
Martinez, Altea Esteve
Zaragoza Ninet, Violeta
Casals Andreu, Miquel
Perez, Sara I. Palencia
Hernandez, Jose Suarez
Dorta Alom, Sara
Feliciano Divasson, Laura
Batalla Cebey, Ana
Gutierrez, Manuel Galan
de Lucas Laguna, Raul
JEADV CLINICAL PRACTICE, 2025,
[29] Which patients will benefit from Romosozumab? A real-life descriptive study
Belen Zanchetta, Maria
Gonzalez Pernas, Mariana
Pingel, Jesica
Lopaczek, Natalia
Jerkovich, Fernando
Sarli, Marcelo
Sosa, Soledad
Conejos, Lorena
Slavinsky, Patricia
Garibaldi, Paula
Longobardi, Vanesa
JOURNAL OF BONE AND MINERAL RESEARCH, 2023, 38 : 275 - 276
[30] Real-life experience with remdesivir for treatment of COVID-19 among older adults: a multicentre retrospective study
Margalit, Ili
Tiseo, Giusy
Ripa, Marco
Borghi, Vanni
Green, Hefziba
Prendki, Virginie
Riccardi, Niccolo
Perego, Giovanni Battista
Grembiale, Alessandro
Galli, Laura
Tinelli, Marco
Castagna, Antonella
Mussini, Cristina
Falcone, Marco
Yahav, Dafna
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2023, 78 (06) : 1505 - 1509

← 1 2 3 4 5 →